FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

416859008: Exenatide (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2005. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2547069015 Exenatide (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
2549393011 Exenatide en Synonym Active Entire term case insensitive SNOMED CT core module
2553971011 Exendin 4 en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Exenatide Is a Substance with glucagon-like peptide 1 receptor agonist mechanism of action (substance) true Inferred relationship Existential restriction modifier
Exenatide Has disposition Hormone false Inferred relationship Existential restriction modifier
Exenatide Has disposition Glucagon-like peptide 1 receptor agonist true Inferred relationship Existential restriction modifier
Exenatide Is a Polypeptide true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing exenatide Has active ingredient True Exenatide Inferred relationship Existential restriction modifier 1
Exenatide 250mcg/mL injection solution prefilled pen Has active ingredient False Exenatide Inferred relationship Existential restriction modifier
Exenatide 250micrograms/mL injection solution 1.2mL prefilled pen Has active ingredient False Exenatide Inferred relationship Existential restriction modifier
Exenatide 250micrograms/mL injection solution 2.4mL prefilled pen Has active ingredient False Exenatide Inferred relationship Existential restriction modifier
Exenatide Has active ingredient True Exenatide Inferred relationship Existential restriction modifier 1
Product containing precisely exenatide 250 microgram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Exenatide Inferred relationship Existential restriction modifier 1
Product containing precisely exenatide 250 microgram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Exenatide Inferred relationship Existential restriction modifier 1
Product containing exenatide in parenteral dose form (medicinal product form) Has active ingredient True Exenatide Inferred relationship Existential restriction modifier 1
Product containing only exenatide in parenteral dose form (medicinal product form) Has active ingredient True Exenatide Inferred relationship Existential restriction modifier 1
Product containing precisely exenatide 2 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has precise active ingredient True Exenatide Inferred relationship Existential restriction modifier 1
Product containing precisely exenatide 2 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has basis of strength substance True Exenatide Inferred relationship Existential restriction modifier 1
Byetta 10micrograms/0.04ml solution for injection 2.4ml pre-filled pens (Ethigen Ltd) Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Byetta 10micrograms/0.04ml solution for injection 2.4ml pre-filled pens (Ethigen Ltd) 1 pre-filled disposable injection Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Byetta 10micrograms/0.04ml solution for injection 2.4ml pre-filled pens (Mawdsley-Brooks & Company Ltd) 1 pre-filled disposable injection Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Byetta 10micrograms/0.04ml solution for injection 2.4ml pre-filled pens (Mawdsley-Brooks & Company Ltd) Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Byetta 10micrograms/0.04ml solution for injection 2.4ml pre-filled pens (CST Pharma Ltd) Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Byetta 10micrograms/0.04ml solution for injection 2.4ml pre-filled pens (CST Pharma Ltd) 1 pre-filled disposable injection Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Bydureon 2mg powder and solvent for prolonged-release suspension for injection pre-filled pens (CST Pharma Ltd) Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Bydureon 2mg powder and solvent for prolonged-release suspension for injection pre-filled pens (CST Pharma Ltd) 4 pre-filled disposable injection Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Exenatide 2mg/0.85ml prolonged-release suspension for injection pre-filled disposable devices Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Exenatide 2mg/0.85ml prolonged-release suspension for injection pre-filled disposable devices 4 pre-filled disposable injection Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Exenatide 2mg/0.85ml prolonged-release suspension for injection pre-filled disposable devices Has active ingredient False Exenatide Inferred relationship Existential restriction modifier
Byetta 10micrograms/0.04ml solution for injection 2.4ml pre-filled pens (Pharmaram Ltd) Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Byetta 10micrograms/0.04ml solution for injection 2.4ml pre-filled pens (Pharmaram Ltd) 1 pre-filled disposable injection Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Bydureon BCise 2mg/0.85ml prolonged-release suspension for injection pre-filled pens (AstraZeneca UK Ltd) 4 pre-filled disposable injection Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Bydureon BCise 2mg/0.85ml prolonged-release suspension for injection pre-filled pens (AstraZeneca UK Ltd) Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Byetta 5micrograms/0.02ml solution for injection 1.2ml pre-filled pens (DE Pharmaceuticals) 1 pre-filled disposable injection Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Byetta 10micrograms/0.04ml solution for injection 2.4ml pre-filled pens (DE Pharmaceuticals) Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Byetta 10micrograms/0.04ml solution for injection 2.4ml pre-filled pens (DE Pharmaceuticals) 1 pre-filled disposable injection Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Byetta 5micrograms/0.02ml solution for injection 1.2ml pre-filled pens (DE Pharmaceuticals) Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Exenatide 10micrograms/0.04ml solution for injection 2.4ml pre-filled disposable devices Has active ingredient False Exenatide Inferred relationship Existential restriction modifier
Exenatide 5micrograms/0.02ml solution for injection 1.2ml pre-filled disposable devices Has active ingredient False Exenatide Inferred relationship Existential restriction modifier
Byetta 10micrograms/0.04ml solution for injection 2.4ml pre-filled pens (AstraZeneca UK Ltd) Has active ingredient True Exenatide Inferred relationship Existential restriction modifier
Byetta 5micrograms/0.02ml solution for injection 1.2ml pre-filled pens (AstraZeneca UK Ltd) Has active ingredient True Exenatide Inferred relationship Existential restriction modifier
Exenatide 5micrograms/0.02ml solution for injection 1.2ml pre-filled disposable devices 1 pre-filled disposable injection Has active ingredient False Exenatide Inferred relationship Existential restriction modifier
Exenatide 10micrograms/0.04ml solution for injection 2.4ml pre-filled disposable devices 1 pre-filled disposable injection Has active ingredient False Exenatide Inferred relationship Existential restriction modifier
Byetta 5micrograms/0.02ml solution for injection 1.2ml pre-filled pens (AstraZeneca UK Ltd) 1 pre-filled disposable injection 60 doses Has active ingredient False Exenatide Inferred relationship Existential restriction modifier
Byetta 10micrograms/0.04ml solution for injection 2.4ml pre-filled pens (AstraZeneca UK Ltd) 1 pre-filled disposable injection 60 doses Has active ingredient False Exenatide Inferred relationship Existential restriction modifier
Byetta 10micrograms/0.04ml solution for injection 2.4ml pre-filled pens (AstraZeneca UK Ltd) 1 pre-filled disposable injection 60 doses Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Exenatide 10micrograms/0.04ml solution for injection 2.4ml pre-filled disposable devices 1 pre-filled disposable injection Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Exenatide 10micrograms/0.04ml solution for injection 2.4ml pre-filled disposable devices Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Byetta 10micrograms/0.04ml solution for injection 2.4ml pre-filled pens (AstraZeneca UK Ltd) Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Byetta 5micrograms/0.02ml solution for injection 1.2ml pre-filled pens (AstraZeneca UK Ltd) 1 pre-filled disposable injection 60 doses Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Exenatide 5micrograms/0.02ml solution for injection 1.2ml pre-filled disposable devices Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Exenatide 5micrograms/0.02ml solution for injection 1.2ml pre-filled disposable devices 1 pre-filled disposable injection Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Byetta 5micrograms/0.02ml solution for injection 1.2ml pre-filled pens (AstraZeneca UK Ltd) Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Byetta 5micrograms/0.02ml solution for injection 1.2ml pre-filled pens (Mawdsley-Brooks & Company Ltd) Has active ingredient True Exenatide Inferred relationship Existential restriction modifier
Byetta 5micrograms/0.02ml solution for injection 1.2ml pre-filled pens (Mawdsley-Brooks & Company Ltd) Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Byetta 5micrograms/0.02ml solution for injection 1.2ml pre-filled pens (Mawdsley-Brooks & Company Ltd) 1 pre-filled disposable injection Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Exenatide 2mg powder and solvent for suspension for injection vials Has active ingredient False Exenatide Inferred relationship Existential restriction modifier
Exenatide 2mg powder and solvent for suspension for injection vials Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Bydureon 2mg powder and solvent for suspension for injection vials (Eli Lilly and Company Ltd) Has active ingredient True Exenatide Inferred relationship Existential restriction modifier
Bydureon 2mg powder and solvent for suspension for injection vials (Eli Lilly and Company Ltd) Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Exenatide 2mg powder and solvent for suspension for injection vials 4 vial Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Bydureon 2mg powder and solvent for suspension for injection vials (Eli Lilly and Company Ltd) 4 vial Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Exenatide 2mg powder and solvent for suspension for injection pre-filled disposable devices Has active ingredient False Exenatide Inferred relationship Existential restriction modifier
Exenatide 2mg powder and solvent for suspension for injection pre-filled disposable devices Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Bydureon 2mg powder and solvent for prolonged-release suspension for injection pre-filled pens (AstraZeneca UK Ltd) Has active ingredient True Exenatide Inferred relationship Existential restriction modifier
Bydureon 2mg powder and solvent for prolonged-release suspension for injection pre-filled pens (AstraZeneca UK Ltd) Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Exenatide 2mg powder and solvent for suspension for injection pre-filled disposable devices 4 pre-filled disposable injection Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Bydureon 2mg powder and solvent for prolonged-release suspension for injection pre-filled pens (AstraZeneca UK Ltd) 4 pre-filled disposable injection Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Byetta 10micrograms/0.04ml solution for injection 2.4ml pre-filled pens (Lexon (UK) Ltd) Has active ingredient True Exenatide Inferred relationship Existential restriction modifier
Byetta 10micrograms/0.04ml solution for injection 2.4ml pre-filled pens (Lexon (UK) Ltd) Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Bydureon 2mg powder and solvent for suspension for injection vials (Lexon (UK) Ltd) Has active ingredient True Exenatide Inferred relationship Existential restriction modifier
Bydureon 2mg powder and solvent for suspension for injection vials (Lexon (UK) Ltd) Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Byetta 10micrograms/0.04ml solution for injection 2.4ml pre-filled pens (Lexon (UK) Ltd) 1 pre-filled disposable injection Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Bydureon 2mg powder and solvent for suspension for injection vials (Lexon (UK) Ltd) 4 vial Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Byetta 5micrograms/0.02ml solution for injection 1.2ml pre-filled pens (Waymade Healthcare Plc) Has active ingredient True Exenatide Inferred relationship Existential restriction modifier
Byetta 5micrograms/0.02ml solution for injection 1.2ml pre-filled pens (Waymade Healthcare Plc) Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Byetta 5micrograms/0.02ml solution for injection 1.2ml pre-filled pens (Waymade Healthcare Plc) 1 pre-filled disposable injection Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Byetta 10micrograms/0.04ml solution for injection 2.4ml pre-filled pens (Originalis B.V.) Has active ingredient True Exenatide Inferred relationship Existential restriction modifier
Byetta 10micrograms/0.04ml solution for injection 2.4ml pre-filled pens (Originalis B.V.) Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier
Byetta 10micrograms/0.04ml solution for injection 2.4ml pre-filled pens (Originalis B.V.) 1 pre-filled disposable injection Has specific active ingredient True Exenatide Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start